| Financial Year |
March 31 2023 |
| Monetary Funds |
2,402,236,060.00 |
| Held-for-trading Financial Assets |
28,203,645.00 |
| Notes Receivable |
511,866,090.00 |
| Accounts Receivable |
2,800,655,705.00 |
| Advances to Suppliers |
602,252,304.00 |
| Other Receivables |
42,519,534.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,660,463,138.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
8,676,290.00 |
| Other Current Assets |
147,522,043.00 |
| Total Current Assets |
11,310,138,409.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
63,711,139.00 |
| Long-term Equity Investment |
74,494,998.00 |
| Investment Properties |
87,315,551.00 |
| Fixed Assetes |
13,482,649,232.00 |
| Under-construction Projects |
7,889,874,306.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
925,942,648.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,443,986.00 |
| Deferred Income Tax Assets |
673,888,816.00 |
| Other Non-Current Assets |
2,478,916,988.00 |
| Sub-Total of Non-Current Assets |
26,361,605,072.00 |
| Total Assets |
37,671,743,481.00 |
| Short-Term Loans |
6,459,311,082.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,369,946,343.00 |
| Accounts Payable |
3,142,950,110.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
145,778,639.00 |
| Taxes Payable |
51,230,350.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,856,036,624.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
562,134,590.00 |
| Other Current Liabilities |
41,418,834.00 |
| Sub-Total of Current Liabilities |
14,946,118,899.00 |
| Long-term Loans |
2,128,713,471.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
217,957,817.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,652,243.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,305,346,073.00 |
| Total Liabilities |
18,251,464,972.00 |
| Paid-In Capital(Or Share Stock) |
1,476,731,513.00 |
| Capital Surplus |
8,947,118,038.00 |
| Surplus Reserve |
516,887,059.00 |
| LESS:Treasury Stock |
220,727,145.00 |
| Undistributed Profits |
8,599,387,838.00 |
| Minority Stockholder's Interest |
5,824,402.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
19,414,454,107.00 |
| Owner's Equity（Stockholder's Equity） |
19,420,278,509.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
37,671,743,481.00 |
